Dosing & Uses
Dosage Forms & Strengths
caplet
- 500mg
powder
- 2g/scoop
Constipation
2 caplets up to 6 times/day; not to exceed 12 caplets/day; follow each dose with 8 oz of water
Alternatively, 1 heaping tablespoon (2 g) in 8 oz water qDay to q8hr
Dosage Forms & Strengths
caplet
- 500mg
powder
- 2g/scoop
Constipation (6-11 Years Old)
<6 years
- Safety & efficacy not established
6-12 years old
- 1 caplet up to 6 times/day; not to exceed 6 caplets/day
- 1 g (½ tablespoon) in 8 oz of cold water; may increase to 1 tablespoon q8hr
>12 years
- 2 caplets up to 6 times/day; not to exceed 12 caplets/day; follow each dose with 8 oz of water
- Alternatively, 1 heaping tablespoon (2 g) in 8 oz water qDay to q8hr
Interactions
Interaction Checker
No Results

Contraindicated
Serious - Use Alternative
Significant - Monitor Closely
Minor

Contraindicated (0)
Serious - Use Alternative (0)
Monitor Closely (0)
Minor (1)
- sodium picosulfate
methylcellulose decreases effects of sodium picosulfate by Mechanism: unspecified interaction mechanism. Minor/Significance Unknown.
Adverse Effects
Frequency Not Defined
Flatulence
Impaction
Excessive bowel activity
Warnings
Contraindications
Hypersensitivity, bowel obstruction, symptoms of appendicitis or acute surgical abdomen, GI ulceration/adhesions, fecal impaction, dysphagia, rectal bleeding
Pregnancy & Lactation
Pregnancy Category: NA (supplement; not a drug)
Lactation: No data available; not absorbed, unlikely to pose risk in breastfeeding
Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available.Pharmacology
Mechanism of Action
Bulk producing laxative
Pharmacokinetics
Metabolism: Not absorbed from GI tract